288 related articles for article (PubMed ID: 29107960)
21. Accelerated lipid catabolism and autophagy are cancer survival mechanisms under inhibited glutaminolysis.
Halama A; Kulinski M; Dib SS; Zaghlool SB; Siveen KS; Iskandarani A; Zierer J; Prabhu KS; Satheesh NJ; Bhagwat AM; Uddin S; Kastenmüller G; Elemento O; Gross SS; Suhre K
Cancer Lett; 2018 Aug; 430():133-147. PubMed ID: 29777783
[TBL] [Abstract][Full Text] [Related]
22. ALKBH7 drives a tissue and sex-specific necrotic cell death response following alkylation-induced damage.
Jordan JJ; Chhim S; Margulies CM; Allocca M; Bronson RT; Klungland A; Samson LD; Fu D
Cell Death Dis; 2017 Jul; 8(7):e2947. PubMed ID: 28726787
[TBL] [Abstract][Full Text] [Related]
23. DNA-PKcs, a novel functional target of acriflavine, mediates acriflavine's p53-dependent synergistic anti-tumor efficiency with melphalan.
Cao J; Lin G; Gong Y; Pan P; Ma Y; Huang P; Ying M; Hou T; He Q; Yang B
Cancer Lett; 2016 Dec; 383(1):115-124. PubMed ID: 27693638
[TBL] [Abstract][Full Text] [Related]
24. Targeting GLS1 to cancer therapy through glutamine metabolism.
Yu W; Yang X; Zhang Q; Sun L; Yuan S; Xin Y
Clin Transl Oncol; 2021 Nov; 23(11):2253-2268. PubMed ID: 34023970
[TBL] [Abstract][Full Text] [Related]
25. Increasing DNA repair capacity in bone marrow by gene transfer as a prospective tool in cancer therapy.
Kleibl K; Margison GP
Neoplasma; 1998; 45(4):181-6. PubMed ID: 9890659
[TBL] [Abstract][Full Text] [Related]
26. Rational design of an AKR1C3-resistant analog of PR-104 for enzyme-prodrug therapy.
Mowday AM; Ashoorzadeh A; Williams EM; Copp JN; Silva S; Bull MR; Abbattista MR; Anderson RF; Flanagan JU; Guise CP; Ackerley DF; Smaill JB; Patterson AV
Biochem Pharmacol; 2016 Sep; 116():176-87. PubMed ID: 27453434
[TBL] [Abstract][Full Text] [Related]
27. mTORC1-Dependent Metabolic Reprogramming Underlies Escape from Glycolysis Addiction in Cancer Cells.
Pusapati RV; Daemen A; Wilson C; Sandoval W; Gao M; Haley B; Baudy AR; Hatzivassiliou G; Evangelista M; Settleman J
Cancer Cell; 2016 Apr; 29(4):548-562. PubMed ID: 27052953
[TBL] [Abstract][Full Text] [Related]
28. Synergy of irofulven in combination with other DNA damaging agents: synergistic interaction with altretamine, alkylating, and platinum-derived agents in the MV522 lung tumor model.
Kelner MJ; McMorris TC; Rojas RJ; Estes LA; Suthipinijtham P
Cancer Chemother Pharmacol; 2008 Dec; 63(1):19-26. PubMed ID: 18305940
[TBL] [Abstract][Full Text] [Related]
29. Recent Development of Small Molecule Glutaminase Inhibitors.
Song M; Kim SH; Im CY; Hwang HJ
Curr Top Med Chem; 2018; 18(6):432-443. PubMed ID: 29793408
[TBL] [Abstract][Full Text] [Related]
30. Glutaminase inhibitor CB-839 increases radiation sensitivity of lung tumor cells and human lung tumor xenografts in mice.
Boysen G; Jamshidi-Parsian A; Davis MA; Siegel ER; Simecka CM; Kore RA; Dings RPM; Griffin RJ
Int J Radiat Biol; 2019 Apr; 95(4):436-442. PubMed ID: 30557074
[TBL] [Abstract][Full Text] [Related]
31. Environmental cystine drives glutamine anaplerosis and sensitizes cancer cells to glutaminase inhibition.
Muir A; Danai LV; Gui DY; Waingarten CY; Lewis CA; Vander Heiden MG
Elife; 2017 Aug; 6():. PubMed ID: 28826492
[TBL] [Abstract][Full Text] [Related]
32. Noncanonical regulation of alkylation damage resistance by the OTUD4 deubiquitinase.
Zhao Y; Majid MC; Soll JM; Brickner JR; Dango S; Mosammaparast N
EMBO J; 2015 Jun; 34(12):1687-703. PubMed ID: 25944111
[TBL] [Abstract][Full Text] [Related]
33. Inhibition of glutaminolysis in combination with other therapies to improve cancer treatment.
Shen YA; Chen CL; Huang YH; Evans EE; Cheng CC; Chuang YJ; Zhang C; Le A
Curr Opin Chem Biol; 2021 Jun; 62():64-81. PubMed ID: 33721588
[TBL] [Abstract][Full Text] [Related]
34. Troxerutin (TXN) potentiated 5-Fluorouracil (5-Fu) treatment of human gastric cancer through suppressing STAT3/NF-κB and Bcl-2 signaling pathways.
Xu GY; Tang XJ
Biomed Pharmacother; 2017 Aug; 92():95-107. PubMed ID: 28531805
[TBL] [Abstract][Full Text] [Related]
35. Oncometabolites d- and l-2-Hydroxyglutarate Inhibit the AlkB Family DNA Repair Enzymes under Physiological Conditions.
Chen F; Bian K; Tang Q; Fedeles BI; Singh V; Humulock ZT; Essigmann JM; Li D
Chem Res Toxicol; 2017 Apr; 30(4):1102-1110. PubMed ID: 28269980
[TBL] [Abstract][Full Text] [Related]
36. PEG-PHB-glutaminase nanoparticle inhibits cancer cell proliferation in vitro through glutamine deprivation.
Pandian SR; Deepak V; Nellaiah H; Sundar K
In Vitro Cell Dev Biol Anim; 2015 Apr; 51(4):372-80. PubMed ID: 25424834
[TBL] [Abstract][Full Text] [Related]
37. A novel small molecule hybrid of vorinostat and DACA displays anticancer activity against human hormone-refractory metastatic prostate cancer through dual inhibition of histone deacetylase and topoisomerase I.
Yu CC; Pan SL; Chao SW; Liu SP; Hsu JL; Yang YC; Li TK; Huang WJ; Guh JH
Biochem Pharmacol; 2014 Aug; 90(3):320-30. PubMed ID: 24915421
[TBL] [Abstract][Full Text] [Related]
38. Protein phosphatase 5 promotes hepatocarcinogenesis through interaction with AMP-activated protein kinase.
Chen YL; Hung MH; Chu PY; Chao TI; Tsai MH; Chen LJ; Hsiao YJ; Shih CT; Hsieh FS; Chen KF
Biochem Pharmacol; 2017 Aug; 138():49-60. PubMed ID: 28528695
[TBL] [Abstract][Full Text] [Related]
39. Fluorescence Monitoring of the Oxidative Repair of DNA Alkylation Damage by ALKBH3, a Prostate Cancer Marker.
Beharry AA; Lacoste S; O'Connor TR; Kool ET
J Am Chem Soc; 2016 Mar; 138(11):3647-50. PubMed ID: 26967262
[TBL] [Abstract][Full Text] [Related]
40. Glutamine Addiction in Kidney Cancer Suppresses Oxidative Stress and Can Be Exploited for Real-Time Imaging.
Abu Aboud O; Habib SL; Trott J; Stewart B; Liang S; Chaudhari AJ; Sutcliffe J; Weiss RH
Cancer Res; 2017 Dec; 77(23):6746-6758. PubMed ID: 29021138
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
